Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.

Drug metabolism and personalized therapy - 1 Jun 2015

Claudio-Campos Karla, Duconge Jorge, Cadilla Carmen L, Ruaño Gualberto

Abstract excerpt

Although the Hispanic population is continuously growing in the United States, they are underrepresented in pharmacogenetic studies. This review addresses the need for compiling available pharmacogenetic data in US Hispanics, discussing the prevalence of clinically relevant polymorphisms in pharmacogenes encoding for drug-metabolizing enzymes. CYP3A5*3 (0.245-0.867) showed the largest frequency in a US Hispanic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Cytochrome P-450 Enzyme System
Share to Glucuronosyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to Hispanic or Latino

Share to Pharmaceutical Preparations

Share to Prevalence

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 25431893
DOI: 10.1515/dmdi-2014-0023
PMCID: PMC4447600

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.PMID 25431893Read ↗

Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.Semantic proximity Read ↗

Major Allele Frequencies in <em>CYP2C9</em> and <em>CYP2C19</em> in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial CategoriesSemantic proximity Read ↗

Exploring Variation in Known Pharmacogenetic Variants and its Association with Drug Response in Different Mexican Populations.Semantic proximity Read ↗

Major Allele Frequencies in CYP2C9 and CYP2C19 in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial CategoriesSemantic proximity Read ↗

Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.Semantic proximity Read ↗

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.Semantic proximity Read ↗

Clinical genetic variation across Hispanic populations in the Mexican Biobank.Semantic proximity Read ↗

Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.Semantic proximity Read ↗

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Semantic proximity Read ↗

Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations.Semantic proximity Read ↗

Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.Semantic proximity Read ↗

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.